Evidence map›Paper›PMID 24662832›Full record

ArticleOncogene2015

Basonuclin-1 modulates epithelial plasticity and TGF-β1-induced loss of epithelial cell integrity.

A Feuerborn, D Mathow, P K Srivastava, N Gretz, H-J Gröne

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

A FeuerbornDepartment of Cellular and Molecular Pathology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
D MathowDepartment of Cellular and Molecular Pathology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
P K SrivastavaPhysiological Genomics and Medicine, MRC Clinical Sciences, Imperial College, London, UK.
N GretzDepartment of Medical Research, Faculty of Medicine, Medical Research Centre (ZMF), University of Heidelberg, Mannheim, Germany.
H-J GröneDepartment of Cellular and Molecular Pathology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
Heidelberg University · DEGenomics England · GBGerman Cancer Research Center · DEUniversity Medical Centre Mannheim · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transforming growth factor-β1 (TGF-β1) is a multifunctional cytokine and critically involved in the progression of a variety of cancers. TGF-β1 signaling can impair tumor development by its anti-proliferative and pro-apoptotic features. In contrast, it may actively promote tumor progression and cancer cell dissemination by inducing a gradual switch from epithelial towards mesenchymal-like cell features (EMT-like), including decreased intercellular adhesion. Here, we show that expression of the transcription factor Basonuclin-1 (Bnc1) modulates TGF-β1-induced epithelial dedifferentiation of mammary epithelial cells. RNAi-mediated repression of Bnc1 resulted in enhanced intercellular adhesion and strongly impaired TGF-β1-dependent sheet disintegration and cell scattering. In contrast, forced expression of Bnc1 modifies plasma membrane/cytoskeletal dynamics and seemingly interferes with the initiation of sustainable cell-cell contacts. Follow-up analyses revealed that Bnc1 affects the expression of numerous TGF-β1-responsive genes including distinct EMT-related transcription factors, some of which modulate the expression of Bnc1 themselves. These results suggest that Bnc1 is part of a transcription factor network related to epithelial plasticity with reciprocal feedback-loop connections on which Smad-factors integrate TGF-β1 signaling. Our study demonstrates that Bnc1 regulates epithelial plasticity of mammary epithelial cells and influences outcome of TGF-β1 signaling.

Indexed as

Signal TransductionCell DedifferentiationCell Transformation, NeoplasticDNA-Binding ProteinsEpithelial CellsEpithelial-Mesenchymal TransitionHomeodomain ProteinsHumansMammary Glands, HumanTranscription FactorsTransforming Growth Factor beta1Zinc Finger E-box-Binding Homeobox 1BNC1 protein, humanDNA-Binding ProteinsHomeodomain ProteinsTranscription FactorsTransforming Growth Factor beta1ZEB1 protein, humanZinc Finger E-box-Binding Homeobox 1

Identifiers

PMID24662832
OpenAlexW2006018132

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.